JP2005530703A - 生物学的に活性な複合体 - Google Patents

生物学的に活性な複合体 Download PDF

Info

Publication number
JP2005530703A
JP2005530703A JP2003573013A JP2003573013A JP2005530703A JP 2005530703 A JP2005530703 A JP 2005530703A JP 2003573013 A JP2003573013 A JP 2003573013A JP 2003573013 A JP2003573013 A JP 2003573013A JP 2005530703 A JP2005530703 A JP 2005530703A
Authority
JP
Japan
Prior art keywords
lactalbumin
cis
complex
protein
fatty acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2003573013A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005530703A5 (enExample
Inventor
カタリナ・スヴァンボルイ
マーリン・ヴィルヘルミナ・スヴェンソン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2005530703A publication Critical patent/JP2005530703A/ja
Publication of JP2005530703A5 publication Critical patent/JP2005530703A5/ja
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2003573013A 2002-03-07 2003-03-07 生物学的に活性な複合体 Abandoned JP2005530703A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0205347.8A GB0205347D0 (en) 2002-03-07 2002-03-07 Biologically active complex
PCT/IB2003/001293 WO2003074547A2 (en) 2002-03-07 2003-03-07 Biologically active complex comprising alpha-lcatalbumin or a variant thereof, and a cofactor

Publications (2)

Publication Number Publication Date
JP2005530703A true JP2005530703A (ja) 2005-10-13
JP2005530703A5 JP2005530703A5 (enExample) 2006-04-20

Family

ID=9932477

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003573013A Abandoned JP2005530703A (ja) 2002-03-07 2003-03-07 生物学的に活性な複合体

Country Status (6)

Country Link
US (1) US20050085416A1 (enExample)
EP (1) EP1485413A2 (enExample)
JP (1) JP2005530703A (enExample)
AU (1) AU2003214522A1 (enExample)
GB (1) GB0205347D0 (enExample)
WO (1) WO2003074547A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210464D0 (en) 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment
EP1727561A1 (en) * 2004-02-26 2006-12-06 HAMLET Pharma AB Lactalbumin for inhibiting angiogenesis
EP1715334A1 (fr) * 2005-04-22 2006-10-25 Adamant Technologies SA Procédé utilisant un capteur électrochimique et électrodes formant ce capteur
GB0518720D0 (en) * 2005-09-14 2005-10-19 Hamlet Pharma Ab Therapeutic combination
JP5679992B2 (ja) 2009-01-09 2015-03-04 ハムレット・ファルマ・アーベー 複合体および生産方法
WO2010131237A1 (en) * 2009-05-13 2010-11-18 Agriculture And Food Development Authority (Teagasc) A process for producing a biologically active globular protein complex
ES2613986T3 (es) 2010-11-24 2017-05-29 Hamlet Pharma Ab Complejo biológicamente activo y su preparación
PL2882446T3 (pl) 2012-08-09 2018-10-31 Hamlet Pharma Ab Terapia profilaktyczna i nutraceutyczna
WO2016133991A1 (en) 2015-02-17 2016-08-25 Xylem Ip Uk Sarl Technique for temperature controlling polarimeter sample cells
IT201700104446A1 (it) * 2017-09-19 2019-03-19 Lo Li Pharma Srl Compositions, uses and methods for treatment of infertility and subfertility

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053185B1 (en) * 1997-11-21 2006-05-30 Hamlet Pharma Ab Lactalbumin production process

Also Published As

Publication number Publication date
AU2003214522A1 (en) 2003-09-16
WO2003074547A2 (en) 2003-09-12
EP1485413A2 (en) 2004-12-15
GB0205347D0 (en) 2002-04-24
AU2003214522A8 (en) 2003-09-16
WO2003074547A3 (en) 2003-11-27
US20050085416A1 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
JP5575639B2 (ja) 改善された特性を有する再構成サーファクタント
US12331073B2 (en) Preparation of biologically active complexes
JP5550634B2 (ja) 新規抗菌ペプチド
JP5679992B2 (ja) 複合体および生産方法
JP5405307B2 (ja) 改善された性質を有する再構成サーファクタント
US20090110756A1 (en) Methods and Compositions Related to PLUNC Surfactant Polypeptides
JP2014129389A (ja) アルツハイマー病治療方法
KR102122088B1 (ko) 재구성된 폐 계면활성제
JP2005530703A (ja) 生物学的に活性な複合体
US7713533B2 (en) Active complex of α-lactalbumin (HAMLET) and cofactor
JPH01206992A (ja) 塩基性蛋白、その誘導体およびフラグメント、ならびにそれらの用途
WO2007043870A1 (en) Leucine rich composition
JP2023539476A (ja) アネキシンａ１のｎ末端ペプチド製剤及び方法
JP2023545152A (ja) アンフォールディングタンパク質を含む組成物の調製方法
KR19990022634A (ko) 폰 빌레브란트 인자의 치료성 단편
KR20230019089A (ko) 바이러스 감염을 치료하기 위한 계면활성제 단백질 d의 용도
Kathir et al. S100A13–lipid interactions—role in the non-classical release of the acidic fibroblast growth factor
Zaman et al. Novel s-nitrosothiols have potential therapeutic uses for cystic fibrosis
EP3329930A1 (en) Pharmaceuctical compositions
CN112194730A (zh) 一种多肽ti-16及其用途
TW202245823A (zh) 無穩定劑或實質上無穩定劑之含有天凡諾賽普特（ｔａｎｆａｎｅｒｃｅｐｔ）的穩定眼用組成物
KR20240034159A (ko) 폴리펩티드 억제제 및 이의 용도
Harrington Age and cataract-related degradation of crystallins in human lenses
ITMI940621A1 (it) Uso della 4'-desossi-4'-idodoxorubicina per il trattamento della al amiloidosi nella malattia di alzheimer

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060303

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060303

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20070403

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20070403

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20070403

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20070403

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070625

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20080214

A762 Written abandonment of application

Free format text: JAPANESE INTERMEDIATE CODE: A762

Effective date: 20090318